IGF2 and breast carcinoma: Even though it is known that the circulating IGF2 concentration is much higher than that of IGF1, there is limited evidence on its mitogenic activity in relation to breast cancer and disease[47,49,56], thus implications of IGF2 on breast cancer risk are inconclusive.